Chumsri, S., Li, Z., Serie, D. J., Mashadi-Hossein, A., Colon-Otero, G., Song, N., . . . Thompson, E. A. (2019). Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31. J Clin Oncol.
Citação norma ChicagoChumsri, Saranya, et al. "Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31." J Clin Oncol 2019.
Citação norma MLAChumsri, Saranya, et al. "Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31." J Clin Oncol 2019.